Aspire Biopharma Holdings Inc - Warrant — Quarterly Balance Sheet (NASDAQ:ASBPW)

Financials

Total revenue ———-364.11 K1 941 — Gross profit ———-364.11 K884 — Operating expenses 630.77 K2.55 M15.56 M799.89 K1.15 M 20.05 M Selling/general/admin expenses 630.77 K2.68 M15.29 M447 K938.48 K 19.36 M Research & development ——263.09 K352.89 K207.9 K — Operating income -630.77 K-2.55 M-15.56 M-1.16 M-1.15 M -20.41 M Non-Operating Income, Total 93.75 K-9.45 M-384.85 K-1.18 M-705 K -11.72 M Interest expense, net of interest capitalized ——289.93 K527.89 K1.48 M — Non-Operating Income, excl. Interest Expenses 68.25 K-9.45 M-674.78 K-1.71 M-2.19 M -14.02 M Unusual income/expense 25.5 K———— — Pretax income -537.02 K-11.99 M-16.23 M-3.24 M-3.33 M -34.79 M Equity in earnings ————— — Taxes ————0 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -537.02 K-11.99 M-15.94 M-1.98 M-1.85 M -31.77 M Discontinued operations ————— — Net income -537.02 K-11.99 M-15.94 M-1.98 M-1.85 M -31.77 M Dilution adjustment 997.29 K20.86 M——— — Preferred dividends -76.75 K-67.16 K——— — Diluted net income available to common stockholders 537.02 K8.93 M-15.94 M-1.98 M-1.85 M -10.84 M Basic earnings per share (Basic EPS) 2.857.616.81.6-1.6 74.4 Diluted earnings per share (Diluted EPS) 2.857.616.81.6-1.6 74.4 Average basic shares outstanding 194.13 K206.1 K947.25 K1.23 M1.24 M 3.62 M Diluted shares outstanding 194.13 K206.1 K947.25 K1.23 M1.24 M 3.62 M EBITDA ————-142.34 K — EBIT ————-1.15 M — Cost of revenue ————1 057 — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————1 M —